The event type was an Earnings Call for the discussion of quarterly results.
The call was held on Thursday, October 30, 2026, at 5:00 p.m. IST.
The stated purpose was to discuss the Unaudited Financial Results for the quarter and half year ended September 30, 2026 (Q2 FY27).
The meeting was scheduled after the earnings announcement, as indicated by the previous intimation letters dated October 23, 2026 and October 30, 2026.
No specific management participants or their designations were listed in this disclosure.
The transcript of the earnings call has been made available on the Company's website at: www.rpglifesciences.com.
The disclosure does not include any statement indicating that no unpublished price sensitive information (UPSI) will be shared.
Additional Notes Section
This is a compliance filing to inform the exchanges of the transcript's availability; no financial data or presentation summaries were included in this specific announcement.
The document is a follow-up to previous letters dated October 23, 2026 and October 30, 2026.
